Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Corcept Therapeutics - 21 Year Stock Price History | CORT

Historical daily share price chart and data for Corcept Therapeutics since 2004 adjusted for splits and dividends. The latest closing stock price for Corcept Therapeutics as of May 07, 2025 is 70.46.
  • The all-time high Corcept Therapeutics stock closing price was 114.22 on March 31, 2025.
  • The Corcept Therapeutics 52-week high stock price is 117.33, which is 66.5% above the current share price.
  • The Corcept Therapeutics 52-week low stock price is 26.53, which is 62.3% below the current share price.
  • The average Corcept Therapeutics stock price for the last 52 weeks is 49.08.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Corcept Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 64.1351 49.9700 114.2200 49.8500 70.4600 39.83%
2024 34.8991 24.1600 60.8500 21.1000 50.3900 55.14%
2023 25.3578 20.1700 33.8000 19.2000 32.4800 59.92%
2022 23.7509 20.3400 29.9600 16.5300 20.3100 2.58%
2021 22.4923 26.0900 30.5600 17.1000 19.8000 -24.31%
2020 15.8917 12.0600 27.3000 10.1100 26.1600 116.20%
2019 12.4494 13.8200 16.9600 9.7800 12.1000 -9.43%
2018 15.7640 18.1400 25.5000 11.2900 13.3600 -26.02%
2017 13.1858 7.3600 20.7200 7.1100 18.0600 148.76%
2016 5.6999 4.6600 9.7400 3.2800 7.2600 45.78%
2015 4.8432 3.1200 7.1600 2.8100 4.9800 66.00%
2014 3.0302 3.3700 4.4400 1.7400 3.0000 -6.54%
2013 1.8782 1.4800 3.2100 1.4800 3.2100 124.48%
2012 3.2145 3.5000 4.4900 1.2900 1.4300 -58.19%
2011 3.7090 3.9600 4.9900 2.5700 3.4200 -11.40%
2010 3.2694 2.7800 4.4600 2.5100 3.8600 38.85%
2009 1.3239 1.3500 2.9000 0.7500 2.7800 172.55%
2008 2.1209 2.9800 3.7900 0.9100 1.0200 -66.99%
2007 2.2662 1.2000 5.1000 0.7100 3.0900 151.22%
2006 3.3519 3.6400 6.1500 0.7000 1.2300 -66.30%
2005 4.9058 6.0800 6.4100 3.4800 3.6500 -41.60%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.472B $0.675B
Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone), is approved for the once-daily oral treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, suffering from type II diabetes or glucose intolerance and who have failed surgery or are not suitable for surgery.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $96.855B 36.33
Zoetis (ZTS) United States $69.448B 25.91
Daiichi Sankyo, - (DSNKY) Japan $48.042B 24.44
Takeda Pharmaceutical (TAK) Japan $47.919B 10.61
Sandoz Group AG (SDZNY) Switzerland $19.518B 0.00
Summit Therapeutics (SMMT) United States $18.039B 0.00
Merck (MKKGY) Germany $17.790B 14.72
Shionogi (SGIOY) Japan $13.871B 13.90
United Therapeutics (UTHR) United States $13.844B 12.25
Neurocrine Biosciences (NBIX) United States $12.035B 41.22
IPSEN (IPSEY) France $10.376B 0.00
Orion OYJ (ORINY) Finland $9.160B 24.77
Madrigal Pharmaceuticals (MDGL) United States $6.635B 0.00
Stevanato Group S.p.A (STVN) Italy $6.602B 41.92
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Ionis Pharmaceuticals (IONS) United States $5.263B 0.00
Grifols, S.A (GRFS) Spain $5.033B 0.00
Soleno Therapeutics (SLNO) United States $3.726B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.939B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.861B 10.03
Hypermarcas (HYPMY) Brazil $2.407B 15.83
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.238B 12.24
BioCryst Pharmaceuticals (BCRX) United States $2.109B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.078B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.684B 0.00
Guardian Pharmacy Services (GRDN) United States $1.635B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.613B 0.00
Indivior (INDV) United States $1.583B 6.71
Evotec AG (EVO) Germany $1.481B 0.00
ARS Pharmaceuticals (SPRY) United States $1.325B 168.62
Ocular Therapeutix (OCUL) United States $1.123B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.108B 45.06
Dyne Therapeutics (DYN) United States $1.068B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.915B 0.00
Harrow (HROW) United States $0.902B 0.00
Enliven Therapeutics (ELVN) United States $0.896B 0.00
Ardelyx (ARDX) United States $0.885B 0.00
Collegium Pharmaceutical (COLL) United States $0.869B 4.62
AleAnna (ANNA) United States $0.716B 0.00
Cronos Group (CRON) Canada $0.713B 0.00
Xeris Biopharma Holdings (XERS) United States $0.701B 0.00
Organogenesis (ORGO) United States $0.657B 0.00
Akebia Therapeutics (AKBA) United States $0.644B 0.00
KalVista Pharmaceuticals (KALV) United States $0.609B 0.00
Xencor (XNCR) United States $0.568B 0.00
Bioventus (BVS) United States $0.540B 13.73
Savara (SVRA) United States $0.529B 0.00
USANA Health Sciences (USNA) United States $0.529B 11.49
Regulus Therapeutics (RGLS) United States $0.520B 0.00
Relay Therapeutics (RLAY) United States $0.506B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.500B 0.00
Elite Pharmaceuticals (ELTP) United States $0.448B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.434B 0.00
Altimmune (ALT) United States $0.413B 0.00
Zevra Therapeutics (ZVRA) United States $0.411B 0.00
CytoDyn (CYDY) United States $0.401B 0.00
Tourmaline Bio (TRML) United States $0.395B 0.00
Verve Therapeutics (VERV) United States $0.376B 0.00
Siga Technologies (SIGA) United States $0.375B 6.40
Oruka Therapeutics (ORKA) United States $0.357B 0.00
Heron Therapeutics (HRTX) United States $0.345B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.330B 8.92
Aquestive Therapeutics (AQST) United States $0.271B 0.00
Avita Medical (RCEL) United States $0.250B 0.00
Nature's Sunshine Products (NATR) United States $0.243B 22.46
Wellgistics Health (WGRX) United States $0.224B 0.00
MediWound (MDWD) Israel $0.193B 0.00
ProKidney (PROK) United States $0.187B 0.00
OmniAb (OABI) United States $0.187B 0.00
Esperion Therapeutics (ESPR) United States $0.173B 0.00
Journey Medical (DERM) United States $0.161B 0.00
Nanobiotix S.A (NBTX) France $0.156B 0.00
Profound Medical (PROF) Canada $0.145B 0.00
4D Molecular Therapeutics (FDMT) United States $0.144B 0.00
Larimar Therapeutics (LRMR) United States $0.139B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Aclaris Therapeutics (ACRS) United States $0.135B 0.00
Korro Bio (KRRO) United States $0.131B 0.00
Protara Therapeutics (TARA) United States $0.129B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.128B 0.00
Lyell Immunopharma (LYEL) United States $0.124B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.123B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Aldeyra Therapeutics (ALDX) United States $0.120B 0.00
Nektar Therapeutics (NKTR) United States $0.113B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.108B 0.00
Lexeo Therapeutics (LXEO) United States $0.099B 0.00
Galectin Therapeutics (GALT) United States $0.099B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.089B 0.00
VAXART, INC (VXRT) United States $0.089B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Achieve Life Sciences (ACHV) Canada $0.083B 0.00
Dominari Holdings (DOMH) United States $0.082B 0.00
Champions Oncology (CSBR) United States $0.080B 13.20
ESSA Pharma (EPIX) Canada $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.076B 0.00
Cassava Sciences (SAVA) United States $0.075B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.075B 0.00
Telomir Pharmaceuticals (TELO) United States $0.074B 0.00
Fractyl Health (GUTS) United States $0.074B 0.00
Context Therapeutics (CNTX) United States $0.069B 0.00
Inotiv (NOTV) United States $0.068B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Nutriband (NTRB) United States $0.064B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.062B 49.11
Vivani Medical (VANI) United States $0.060B 0.00
Assertio Holdings (ASRT) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Metagenomi (MGX) United States $0.054B 0.00
Karyopharm Therapeutics (KPTI) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Avalo Therapeutics (AVTX) United States $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.034B 0.00
Prelude Therapeutics (PRLD) United States $0.033B 0.00
FibroGen (FGEN) United States $0.033B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
Surrozen (SRZN) United States $0.030B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Jupiter Neurosciences (JUNS) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 7.52
DURECT (DRRX) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.016B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
Scienture Holdings (SCNX) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 8.42
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.22
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Jaguar Animal Health (JAGX) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00